Medicamen Biotech Ltd (MEDICAMEQ) — Sustainability Report | 3 September 2026

Medicamen Biotech Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 to BSE on September 3, 2026, as mandated under SEBI Regulation 34(2)(f). The report details ESG disclosures across governance, environmental impact, social initiatives, and stakeholder engagement. Key highlights include 80% of revenue from exports across 35+ countries, CSR spend of Rs. 25.20 lakhs (against a statutory requirement of Rs. 31.33 lakhs), and compliance with environmental norms like ETP systems and waste management. The company emphasizes product safety, regulatory compliance, and sustainable resource use in its manufacturing operations. No material financial penalties or regulatory actions were noted during the year.